000			02238 a2200649 4500
005			20250515064135.0
264		0	_c20070910
008			200709s 0 0 eng d
022			_a0160-2446
024	7		_a10.1097/FJC.0b013e318032002f _2doi
040			_aNLM _beng _cNLM
100	1		_aWirth, Klaus J
245	0	0	_aIn vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231. _h[electronic resource]
260			_bJournal of cardiovascular pharmacology _cApr 2007
300			_a197-206 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAction Potentials _xdrug effects
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aAnti-Arrhythmia Agents _xpharmacology
650	0	4	_aArrhythmias, Cardiac _xdrug therapy
650	0	4	_aAtrial Function _xdrug effects
650	0	4	_aBlood Flow Velocity _xdrug effects
650	0	4	_aCHO Cells
650	0	4	_aCarbachol _xpharmacology
650	0	4	_aCardiotonic Agents _xpharmacology
650	0	4	_aCricetinae
650	0	4	_aCricetulus
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aElectrophysiologic Techniques, Cardiac
650	0	4	_aFemale
650	0	4	_aGoats
650	0	4	_aGuinea Pigs
650	0	4	_aHeart Atria _xcytology
650	0	4	_aHeart Ventricles _xdrug effects
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aIon Channels _xdrug effects
650	0	4	_aMale
650	0	4	_aMyocytes, Cardiac _xdrug effects
650	0	4	_aPapillary Muscles _xdrug effects
650	0	4	_aPatch-Clamp Techniques
650	0	4	_aPhenethylamines _xpharmacology
650	0	4	_aPotassium Channel Blockers _xpharmacology
650	0	4	_aRefractory Period, Electrophysiological _xdrug effects
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aSwine
650	0	4	_aTime Factors
700	1		_aBrendel, Joachim
700	1		_aSteinmeyer, Klaus
700	1		_aLinz, Dominik K
700	1		_aRütten, Hartmut
700	1		_aGögelein, Heinz
773	0		_tJournal of cardiovascular pharmacology _gvol. 49 _gno. 4 _gp. 197-206
856	4	0	_uhttps://doi.org/10.1097/FJC.0b013e318032002f _zAvailable from publisher's website
999			_c16988733 _d16988733